14-05-2024
|
|
|
STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 22-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
|
|
|
10-05-2024
|
|
|
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 10, 2024, titled "Strides receives USFDA approval for Sevelamer Carbonate Tablets, 800 mg". |
|
|
|
06-05-2024
|
|
|
Strides Pharma Science Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
06-05-2024
|
|
|
STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation |
|
|
|
06-05-2024
|
|
|
STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Loss of share certificates |
|
|
|
30-04-2024
|
|
|
Strides Pharma Science Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
|
|
29-04-2024
|
|
|
Strides Pharma Science Limited has informed the Exchange regarding allotment of 10000 securities pursuant to ESOP/ESPS at its meeting held on April 29, 2024 |
|
|
|
29-04-2024
|
|
|
STRIDES PHARMA SCIENCE LIMITED has informed the Exchange regarding Allotment of Securities |
|
|
|
09-04-2024
|
|
|
Strides Pharma Science Limited has informed the Exchange regarding a press release dated April 09, 2024, titled "Strides receives USFDA approval for Fluoxetine Tabs 10 mg and 20 mg". |
|
|
|
06-04-2024
|
|
|
Strides Pharma Science Limited has informed the Exchange regarding 'Completion of US-FDA Inspection at the Formulations Facility of Strides Alathur Private Limited, a wholly owned subsidiary of the Company'. |
|
|
|
|
|